BioUtah, the trade association representing Utah's life sciences community, announced its participation in the J.P. Morgan 44th Annual Healthcare Conference, scheduled for January 11-16, 2026, in San Francisco. The conference is one of the largest and most influential healthcare investment gatherings globally, bringing together industry leaders, investors, and innovators.
Kelvyn Cullimore, President and CEO of BioUtah, will attend on behalf of the association, representing the more than 1,600 life sciences companies based in Utah. The state has established strengths in medical device manufacturing, diagnostics, biotechnology, pharmaceuticals, and digital health. By attending, BioUtah aims to showcase these capabilities and foster connections that can drive growth and innovation in the sector.
In addition to attending the conference, BioUtah will co-host a state bio reception on Sunday, January 11, 2026, providing an opportunity for networking and collaboration among attendees interested in Utah's life sciences ecosystem. The reception is part of ongoing efforts to attract investment and talent to the state.
The announcement also promotes the upcoming 2026 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit and Snowbird ski day, scheduled for March 12-13, 2026, in Salt Lake City. Early bird registration is now open for the event, which aims to connect entrepreneurs, investors, and industry experts. The summit is a key event for the life sciences community in Utah and beyond.
BioUtah's participation in the J.P. Morgan conference underscores the importance of Utah's life sciences industry to the state's economy and the broader healthcare landscape. The industry is a key driver of economic growth, job creation, and medical advancements. By representing Utah at this major conference, BioUtah hopes to highlight the state's competitive advantages, including its business-friendly environment, skilled workforce, and collaborative culture.
The conference provides a platform for BioUtah to engage with potential partners, investors, and clients, and to raise awareness of Utah's life sciences strengths. With the state's growing reputation as a hub for innovation, BioUtah's presence at the conference is expected to yield significant benefits for its member companies and the industry as a whole.
For more information about BioUtah and its initiatives, visit the full announcement here.
